Target intelligence / Profile preview

Broad wound microorganisms

Molecular classification
Other
01

Overview

Broad wound microorganisms refer to the diverse community of bacteria, fungi, and other pathogens that colonize and infect cutaneous wounds (Bowler et al., 2001). Common species include Staphylococcus aureus, Pseudomonas aeruginosa, and various anaerobic bacteria, which often coexist in complex biofilms (Percival et al., 2015). These organisms impede the natural healing process by secreting proteases and toxins that damage host tissue and degrade the extracellular matrix (Negut et al., 2018). Their presence triggers a prolonged inflammatory response, leading to chronic wounds and potential systemic infection or sepsis (StatPearls, 2023). Therapeutic interventions target these microorganisms through the use of broad-spectrum antibiotics, topical antiseptics, and physical debridement (Negut et al., 2018). Drugs like silver sulfadiazine and mupirocin are frequently employed to reduce microbial load and prevent the spread of infection (StatPearls, 2023). However, the development of antimicrobial resistance and the protective nature of biofilms pose significant challenges to effective treatment (Percival et al., 2015). Understanding the composition and behavior of these microbial communities is essential for developing targeted therapies that promote tissue regeneration and wound closure (Bowler et al., 2001).

Other names
Wound pathogensWound microbiotaWound-infecting organismsWound flora
02

Mechanism of action

Inhibition of microbial cell wall synthesis, protein synthesis, or DNA replication; disruption of cell membrane integrity; oxidative damage to microbial components.

03

Biological functions

PathogenesisBiofilm formationTissue degradationInflammation induction
04

Disease associations

InfectionInflammationSepsis
05

Safety considerations

Antimicrobial resistanceCytotoxicity to host cellsAllergic contact dermatitisSystemic toxicity from topical absorptionDisruption of normal skin flora
06

Interacting drugs

Silver sulfadiazine

8 more in the full profile.

07

Biomarkers

Wound cultureGram stainC-reactive protein (CRP)ProcalcitoninWound pH

Beyond the preview

Go deeper on Broad wound microorganisms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad wound microorganisms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call